Spots Global Cancer Trial Database for taxotere
Every month we try and update this database with for taxotere cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | NCT00936936 | Testicular Canc... | Gemcitabine Docetaxel Melphalan Carboplatin Mesna Ifosfamide Etoposide Stem Cell Trans... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer. | NCT00209729 | Gastric Cancer | Taxotere TS-1 | 76 Years - 80 Years | Hokkaido Gastrointestinal Cancer Study Group | |
| Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer | NCT00066885 | Carcinoma, Non-... | calcitriol + do... | 18 Years - | Novacea | |
| Study of PX-866 and Docetaxel in Solid Tumors | NCT01204099 | Non Small Cell ... Squamous Cell C... | Docetaxel PX-866 | 18 Years - | Seagen Inc. | |
| A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer | NCT00887536 | Breast Cancer | bevacizumab docetaxel doxorubicin cyclophosphamid... pegfilgrastim | 18 Years - 70 Years | NSABP Foundation Inc | |
| Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer | NCT00456989 | Prostate Cancer | Taxotere Doxil | 18 Years - | University of Louisville | |
| Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | NCT00006107 | Head and Neck C... | Taxotere Surgery radiation thera... | 18 Years - | Dana-Farber Cancer Institute | |
| Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients | NCT00952003 | Gastric Cancer Unresectable | Oxaliplatin, Ir... | 18 Years - | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer | NCT00456989 | Prostate Cancer | Taxotere Doxil | 18 Years - | University of Louisville | |
| A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT05863325 | Locally Advance... | HB1801 Taxotere | 18 Years - | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer | NCT00485485 | Head and Neck C... Squamous Cell C... | Imatinib Mesyla... Docetaxel | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer | NCT05705635 | Gastric Adenoca... Adenocarcinoma ... | Docetaxel for i... Taxotere | 18 Years - 75 Years | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer | NCT00215345 | Prostate Cancer | Taxotere Celecoxib | 18 Years - | Department of Veterans Affairs, New Jersey | |
| Adj TC + Herceptin Early Stage Breast Cancer | NCT00493649 | Breast Cancer | Taxotere Cytoxan Herceptin | 18 Years - 70 Years | US Oncology Research | |
| A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC) | NCT00571675 | Hormone Refract... | AT-101, prednis... placebo, predni... | 18 Years - | Ascenta Therapeutics | |
| Trimodality Management of T1b Esophageal Cancers | NCT01217060 | Esophageal Canc... | Docetaxel 5-FU Radiotherapy Esophagectomy Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer | NCT00431054 | Ovarian Cancer | Perifosine Docetaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC) | NCT00418704 | Non Small Cell ... | Erlotinib taxotere | 65 Years - | Groupe Francais De Pneumo-Cancerologie | |
| A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer | NCT00354562 | Lung Cancer Non-Small Cell ... | ABT-751 Placebo Docetaxel | 18 Years - | Abbott | |
| GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer | NCT00089856 | Prostate Cancer | Immunotherapy w... Chemotherapy (T... | 18 Years - | Cell Genesys | |
| A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT05863325 | Locally Advance... | HB1801 Taxotere | 18 Years - | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer | NCT00206453 | Breast Cancer | Taxotere | 18 Years - | Baylor Breast Care Center | |
| DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) | NCT00273338 | Prostate Cancer | calcitriol docetaxel | 18 Years - | Novacea | |
| Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer | NCT00514540 | Prostate Cancer | Docetaxel Carboplatin Etoposide Cisplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer | NCT00052169 | Breast Neoplasm... | ZD1839 in combi... | 18 Years - | NSABP Foundation Inc | |
| Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer | NCT00393939 | Breast Neoplasm... | Sunitinib malat... Taxotere | 18 Years - | Pfizer | |
| VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | NCT00436501 | Fallopian Tube ... Malignant Tumor... Recurrent Ovari... | docetaxel ziv-aflibercept laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation | NCT00186420 | Prostate Cancer | Taxotere | 18 Years - | Stanford University | |
| Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer | NCT00146549 | Breast Cancer Stage IV Breast... | Trastuzumab Vinorelbine Paclitaxel Docetaxel | 18 Years - | Dana-Farber Cancer Institute | |
| VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | NCT00436501 | Fallopian Tube ... Malignant Tumor... Recurrent Ovari... | docetaxel ziv-aflibercept laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer | NCT00050167 | Breast Cancer | Paclitaxel Docetaxel Capecitabine | - | M.D. Anderson Cancer Center | |
| Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC) | NCT00418704 | Non Small Cell ... | Erlotinib taxotere | 65 Years - | Groupe Francais De Pneumo-Cancerologie | |
| Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer | NCT00876070 | Metastatic Brea... | 18 Years - | SCRI Development Innovations, LLC | ||
| Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer. | NCT00209729 | Gastric Cancer | Taxotere TS-1 | 76 Years - 80 Years | Hokkaido Gastrointestinal Cancer Study Group | |
| Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer | NCT00003352 | Breast Cancer | cyclophosphamid... Taxotere Adriamycin | 18 Years - | NSABP Foundation Inc | |
| A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer | NCT02748213 | Breast Cancer | Xeloda Taxotere Herceptin | 18 Years - | Hoffmann-La Roche | |
| Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection | NCT01927744 | Head and Neck C... | Docetaxel Erlotinib Placebo Questionnaires Phone Call Chemotherapy | 18 Years - | M.D. Anderson Cancer Center | |
| Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer | NCT00291577 | Breast Neoplasm... | Sunitinib (Sute... Taxotere | 18 Years - | Pfizer | |
| Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer | NCT01076335 | Prostate Cancer | Neoadjuvant Hor... Docetaxel | - | M.D. Anderson Cancer Center | |
| A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC) | NCT00571675 | Hormone Refract... | AT-101, prednis... placebo, predni... | 18 Years - | Ascenta Therapeutics | |
| Adj TC + Herceptin Early Stage Breast Cancer | NCT00493649 | Breast Cancer | Taxotere Cytoxan Herceptin | 18 Years - 70 Years | US Oncology Research | |
| Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive | NCT00372424 | Breast Cancer | Herceptin Sunitinib Taxotere | 18 Years - | Pfizer | |
| Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT01154920 | Head and Neck S... | Paclitaxel Carboplatin Cetuximab Docetaxel Cisplatin Fluorouracil Radiotherapy (R... Chemotherapy | 18 Years - | M.D. Anderson Cancer Center | |
| Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel | NCT01192165 | Cancer | Trametinib (GSK... Docetaxel Erlotinib Pemetrexed Carboplatin nab-Paclitaxel Cisplatin | 18 Years - | GlaxoSmithKline | |
| The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere | NCT04811118 | Advanced Solid ... | Docetaxel for I... Taxotere | 18 Years - 65 Years | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer | NCT00354562 | Lung Cancer Non-Small Cell ... | ABT-751 Placebo Docetaxel | 18 Years - | Abbott | |
| PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone | NCT00291005 | Prostatic Neopl... | ARD6562, Doceta... | 20 Years - 74 Years | Sanofi | |
| Docetaxel and Sirolimus in Patients With Advanced Malignancies | NCT01054313 | Advanced Cancer | Docetaxel (Taxo... Sirolimus (Rapa... Prednisone | - | M.D. Anderson Cancer Center | |
| Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck | NCT00184028 | Carcinoma of th... | Taxotere Oxaliplatin | 18 Years - | University of Southern California | |
| Neoadjuvant Taxotere | NCT00206505 | Breast Cancer | Taxotere | 18 Years - | Baylor Breast Care Center | |
| A Study of the Efficacy and Safety of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) vs. Trastuzumab (Herceptin®) and Docetaxel (Taxotere®) in Patients With Metastatic HER2-positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease | NCT00679341 | Breast Cancer | Trastuzumab emt... Trastuzumab Docetaxel | 18 Years - | Hoffmann-La Roche | |
| Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC) | NCT01562301 | Chemotherapeuti... Lung Cancer | Carboplatin Docetaxel Anvirzel Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Oxaliplatin and Taxotere in Prostate Cancer | NCT00260611 | Prostate Cancer | Oxaliplatin Taxotere | 18 Years - | University of Pittsburgh | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck | NCT00003200 | Head and Neck C... | Taxotere Radiation thera... | 18 Years - | Dana-Farber Cancer Institute | |
| Study of Irofulven in Patients With Hormone-refractory Prostate Cancer | NCT00124566 | Prostate Cancer | Irofulven Prednisone Mitoxantrone Capecitabine Irofulven | 18 Years - | Eisai Inc. | |
| Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer | NCT00165464 | Esophageal Canc... Gastric Cancer GE Junction Can... | Taxotere Cisplatin Irinotecan | 18 Years - | Dana-Farber Cancer Institute | |
| Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer | NCT00514540 | Prostate Cancer | Docetaxel Carboplatin Etoposide Cisplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | NCT00394433 | Esophageal Canc... Stomach Cancer | Bevacizumab Docetaxel Cisplatin Irinotecan | 18 Years - | Dana-Farber Cancer Institute | |
| Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer | NCT06409390 | Metastatic Brea... | Taxotere Cytoxan Trastuzumab der... Sacituzumab gov... Xeloda Fulvestrant Ribociclib Abemaciclib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC) | NCT01368848 | NSCLC | Bevacizumab Cisplatin Docetaxel | 18 Years - 70 Years | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy | NCT02953184 | Antineoplastic ... | Pegylated Lipos... Cyclophosphamid... Taxotere Dexrazoxane (DZ... vitamin B Doxorubicin Breast Conserve... Modified Radica... Sentinel Lymph ... | 18 Years - 70 Years | Jilin University | |
| A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer | NCT05705635 | Gastric Adenoca... Adenocarcinoma ... | Docetaxel for i... Taxotere | 18 Years - 75 Years | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Simultaneous Integrated Boost (SIB) in Esophageal Cancer | NCT01102088 | Esophageal Canc... | Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer | NCT00076310 | Head and Neck C... | Docetaxel OSI-774 Cisplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer | NCT00876070 | Metastatic Brea... | 18 Years - | SCRI Development Innovations, LLC | ||
| Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck | NCT00184028 | Carcinoma of th... | Taxotere Oxaliplatin | 18 Years - | University of Southern California | |
| PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone | NCT00291005 | Prostatic Neopl... | ARD6562, Doceta... | 20 Years - 74 Years | Sanofi | |
| Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy | NCT00256841 | Carcinoma, Non-... | Chemotherapy Radiation Thera... | - | Clinical Oncology Research Associates | |
| Neoadjuvant Taxotere | NCT00206505 | Breast Cancer | Taxotere | 18 Years - | Baylor Breast Care Center | |
| Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma | NCT01794845 | Squamous Cell C... Head and Neck C... Recurrent Disea... | Erbitux Taxotere Low Dose Fracti... | - | University of Miami | |
| Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer | NCT01076335 | Prostate Cancer | Neoadjuvant Hor... Docetaxel | - | M.D. Anderson Cancer Center | |
| Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer | NCT00052169 | Breast Neoplasm... | ZD1839 in combi... | 18 Years - | NSABP Foundation Inc | |
| Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer | NCT02324543 | Metastatic Panc... | Gemcitabine Taxotere Xeloda Cisplatin Irinotecan | 18 Years - 76 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) | NCT01083589 | Non-small Cell ... | Imatinib Mesyla... Docetaxel | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer | NCT00089479 | Breast Cancer | capecitabine [X... Taxotere Taxotere | 18 Years - 70 Years | Hoffmann-La Roche | |
| Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer | NCT02274610 | Solid Tumor | Docetaxel-PNP Taxotere | 18 Years - | Samyang Biopharmaceuticals Corporation | |
| Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients | NCT00526110 | Gastrointestina... | 5-Fluorouracil Docetaxel Oxaliplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma | NCT00324012 | Adrenocortical ... | cisplatin, taxo... | 18 Years - | Rigshospitalet, Denmark | |
| Docetaxel and Sirolimus in Patients With Advanced Malignancies | NCT01054313 | Advanced Cancer | Docetaxel (Taxo... Sirolimus (Rapa... Prednisone | - | M.D. Anderson Cancer Center | |
| Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer | NCT02274610 | Solid Tumor | Docetaxel-PNP Taxotere | 18 Years - | Samyang Biopharmaceuticals Corporation |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
